| Basics |
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.
|
| IPO Date: |
May 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$95.95M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.22 | 2.98%
|
| Avg Daily Range (30 D): |
$0.06 | 2.64%
|
| Avg Daily Range (90 D): |
$0.04 | 1.92%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.25M |
| Avg Daily Volume (30 D): |
.11M |
| Avg Daily Volume (90 D): |
.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
158 |
| Avg Trade Size (Sh.) (30 D): |
284 |
| Avg Trade Size (Sh.) (90 D): |
275 |
| Institutional Trades |
| Total Inst.Trades: |
113 |
| Avg Inst. Trade: |
$1.66M |
| Avg Inst. Trade (30 D): |
$.63M |
| Avg Inst. Trade (90 D): |
$.63M |
| Avg Inst. Trade Volume: |
.17M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.39M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
297.23K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$.32
|
$-.19
|
$-.26
|
|
Diluted EPS
|
$.31
|
$-.19
|
$-.26
|
|
Revenue
|
$ M
|
$ 2M
|
$
|
|
Gross Profit
|
$ M
|
$ .01M
|
$
|
|
Net Income / Loss
|
$ 13.26M
|
$ -7.64M
|
$ -10.16M
|
|
Operating Income / Loss
|
$ -2.49M
|
$ -4.5M
|
$ -3.6M
|
|
Cost of Revenue
|
$ M
|
$ 1.99M
|
$
|
|
Net Cash Flow
|
$ -38.62M
|
$ M
|
$ 12.32M
|
|
PE Ratio
|
7.52
|
|
|
| Splits |
|
Jan 23, 2013:
1:12
|
|
|
|
